<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

Health Sciences

Alumni    Philanthropy    Pharmacy    Advancement    Health Sciences    Integrative Health    Medicine

CU Pharmacy Alumnus Built a Legacy in Alternative Medicine

Longtime friend and supporter, Henry Leopold Strauss, 93, passed away peacefully on April 8, 2021 at the home where he lived for the past 60 years. Strauss, RPh '51 leaves a lasting legacy with the University and Colorado and the Skaggs School of Pharmacy and Pharmaceutical Sciences, his alma mater.


Author SOP Communications | Publish Date April 30, 2021
Full Story

School of Pharmacy In the News

9News

Clearing medicine cabinets helps combat opioid crisis

news outlet9News
Publish DateApril 30, 2022

Professor Peter Rice, PharmD, PhD and CU Pharmacy students were featured in 9News participating in the DEA’s National Prescription Drug Take Back Day. Their efforts helped get potentially dangerous drugs out of homes.

Full Story
Denver 7

'It can 100% be a gateway': Fort Collins man warns others about keeping unused prescription drugs

news outletDenver 7
Publish DateApril 25, 2022

Professor Robert Page, PharmD, spoke about the National Drug Takeback Day and CU Pharmacy's role in hosting the annual event on campus.

Full Story
Colorado Politics

Let patients benefit from prescription drug reform

news outletColorado Politics
Publish DateApril 22, 2022

Kavita Nair, PhD writes that, "Coloradans continue to struggle to pay for their prescription medications. The largest yearly survey of Colorado households conducted by the Colorado Health Institute found that one in five Coloradans skipped health-care services due to cost concerns in 2021."

Full Story
UK Today News

Newly developed drug shows promise against a novel oncogene that supports cancer progression

news outletUK Today News
Publish DateApril 07, 2022

In findings recently published in the Journal of Medicinal Chemistry, Daniel LaBarbera, PhD and colleagues describe the optimization of the first lead CHD1L inhibitors (CHD1Li) through drug design and medicinal chemistry.

Full Story